These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25926293)

  • 21. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.
    Mauritz GJ; Rizopoulos D; Groepenhoff H; Tiede H; Felix J; Eilers P; Bosboom J; Postmus PE; Westerhof N; Vonk-Noordegraaf A
    Am J Cardiol; 2011 Dec; 108(11):1645-50. PubMed ID: 21890089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
    Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.
    Mathai SC; Bueso M; Hummers LK; Boyce D; Lechtzin N; Le Pavec J; Campo A; Champion HC; Housten T; Forfia PR; Zaiman AL; Wigley FM; Girgis RE; Hassoun PM
    Eur Respir J; 2010 Jan; 35(1):95-104. PubMed ID: 19643943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.
    Koli K; Myllärniemi M; Vuorinen K; Salmenkivi K; Ryynänen MJ; Kinnula VL; Keski-Oja J
    Am J Pathol; 2006 Jul; 169(1):61-71. PubMed ID: 16816361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C: a potential biomarker for pulmonary arterial hypertension.
    Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
    Respirology; 2014 May; 19(4):583-9. PubMed ID: 24628703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension.
    Edwards AL; Gunningham SP; Clare GC; Hayman MW; Smith M; Frampton CM; Robinson BA; Troughton RW; Beckert LE
    Respirology; 2013 Nov; 18(8):1271-7. PubMed ID: 23819819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Tang L; Jia P; Zhao J; Liu D; Liu B
    Pediatr Cardiol; 2016 Apr; 37(4):714-21. PubMed ID: 26714814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
    Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension.
    Costello CM; Howell K; Cahill E; McBryan J; Konigshoff M; Eickelberg O; Gaine S; Martin F; McLoughlin P
    Am J Physiol Lung Cell Mol Physiol; 2008 Aug; 295(2):L272-84. PubMed ID: 18469115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
    Neal JE; Lee AS; Burger CD
    Clin Respir J; 2014 Oct; 8(4):404-9. PubMed ID: 24308300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
    Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
    Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
    Diller GP; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bédard E; Gibbs JS; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J
    Circulation; 2008 Jun; 117(23):3020-30. PubMed ID: 18519847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.
    Pérez-Peñate GM; Rúa-Figueroa I; Juliá-Serdá G; León-Marrero F; García-Quintana A; Ortega-Trujillo JR; Erausquin-Arruabarrena C; Rodríguez-Lozano C; Cabrera-Navarro P; Ojeda-Betancor N; Gómez-Sánchez MÁ
    J Rheumatol; 2016 Feb; 43(2):323-9. PubMed ID: 26669915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-to-mesenchymal transition (EMT) in HK-2 cells.
    Li Y; Wang Z; Wang S; Zhao J; Zhang J; Huang Y
    Toxicology; 2012 Jul; 297(1-3):68-75. PubMed ID: 22525892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients.
    Li ZF; Zhou DX; Wang QB; Pan WZ; Zhang L; Ge JB
    Regul Pept; 2013 May; 183():13-6. PubMed ID: 23499807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.